FinnCap Reiterates “Corporate” Rating for Bioventix PLC (LON:BVXP)

FinnCap reiterated their corporate rating on shares of Bioventix PLC (LON:BVXP) in a report issued on Monday, September 4th.

Bioventix PLC (BVXP) traded up 1.23% on Monday, hitting GBX 2462.50. The stock had a trading volume of 680 shares. The company’s 50 day moving average price is GBX 2,229.19 and its 200 day moving average price is GBX 1,945.75. The firm’s market cap is GBX 124.92 million. Bioventix PLC has a 52-week low of GBX 1,075.00 and a 52-week high of GBX 2,700.00.

WARNING: “FinnCap Reiterates “Corporate” Rating for Bioventix PLC (LON:BVXP)” was originally published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at

About Bioventix PLC

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.

Receive News & Ratings for Bioventix PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix PLC and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply